Salivary Catecholamines in Aphthous Stomatitis (Canker Sores)
NCT ID: NCT00556686
Last Updated: 2015-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2006-08-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Salivary Cytokines as Biomarker for Oral Health
NCT02807519
Caphosol Study: Prevention of Oral Mucositis in Children, Adolescents and Young Adults Receiving Chemotherapy
NCT02539342
Investigation of the Effect of Oral Care With Coconut Oil on the Degree of Oral Mucositis in Pediatric Oncology Patients
NCT05849571
The Effect of Oral Care Protocol on Prevention of Oral Mucositis in Pediatric Cancer Patients
NCT04586491
Luminance RED for Canker Sores
NCT04914533
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Individuals with a history of canker sores.
No interventions assigned to this group
2
Individuals with no history of canker sores.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History of recurrent aphthous ulcers with 4 or more episodes per year
Exclusion Criteria
* History of benign or malignant salivary gland tumor
* History of celiac disease, ulcerative colitis or Crohn's disease
* Patients on medications that affect salivary flow such as anti-depressants and anti-cholinergic medications
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nasim Fazel, MD, DDS
Role: PRINCIPAL_INVESTIGATOR
University of California, Davis
Related Links
Access external resources that provide additional context or updates about the study.
University of California-Davis Department of Dermatology Clinical Research
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
200614581
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.